Original ResearchPublished 22 September 2026Active targeting towards bone cancer and metastases by pamidronate-bridged dinuclear platinum(II) complexesAnna Maria Di Cosola · Alessandra Barbanente · Luisa D’Anna · Simona Rubino · Alessio Terenzi · Mauro Niso · Nicola MargiottaFrontiers in Chemistrydoi 10.3389/fchem.2026.1945537
ReviewPublished 11 September 2026Analysis of the heterogeneity of the immune microenvironment of bone metastases and new strategies of nanotechnology interventionChenyang Wu · Xueli Qiu · Chao Wang · Jinyu Bai · Xiaozhong ZhouOncology Reviewsdoi 10.3389/or.2026.1820639
Mini ReviewPublished 1 September 2026Quantification in bone SPECT/CTJovana Zivanovic · Jules Zhang-YinFrontiers in Nuclear Medicinedoi 10.3389/fnume.2026.1941906
Case ReportPublished 21 August 2026Urothelial carcinoma of the bladder with prostatic stromal invasion and early postoperative bone metastases: a case reportCheng Wang · Mengyun Wang · Yue HeFrontiers in Urologydoi 10.3389/fruro.2026.1910163
ReviewPublished 15 July 2026PSMA-targeted radioligand therapy in advanced prostate cancer: a narrative review of ^177Lu-PSMA, emerging ^225Ac-PSMA strategies, and therapeutic sequencingNatalia Gierulska · Nina Jankowska · Adrianna Kwiatkowska · Piotr Kuchno · Kinga Łysak · Katarzyna Szklener · Kamil Kośmider · Magdalena SkórzewskaOncology Reviewsdoi 10.3389/or.2026.1834484
